CNVI Stock Overview
Focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Conavi Medical Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.66 |
52 Week High | CA$1.52 |
52 Week Low | CA$0.50 |
Beta | 0 |
11 Month Change | -34.65% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -41.33% |
Recent News & Updates
Recent updates
Shareholder Returns
CNVI | CA Medical Equipment | CA Market | |
---|---|---|---|
7D | -1.5% | -3.7% | 0.08% |
1Y | n/a | -13.0% | 23.2% |
Return vs Industry: Insufficient data to determine how CNVI performed against the Canadian Medical Equipment industry.
Return vs Market: Insufficient data to determine how CNVI performed against the Canadian Market.
Price Volatility
CNVI volatility | |
---|---|
CNVI Average Weekly Movement | 26.0% |
Medical Equipment Industry Average Movement | 14.8% |
Market Average Movement | 8.4% |
10% most volatile stocks in CA Market | 17.8% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: CNVI's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine CNVI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Tom Looby | conavi.com |
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada.
Conavi Medical Corp. Fundamentals Summary
CNVI fundamental statistics | |
---|---|
Market cap | CA$36.29m |
Earnings (TTM) | -CA$34.58m |
Revenue (TTM) | CA$3.64m |
8.0x
P/S Ratio-0.8x
P/E RatioIs CNVI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CNVI income statement (TTM) | |
---|---|
Revenue | CA$3.64m |
Cost of Revenue | CA$2.25m |
Gross Profit | CA$1.39m |
Other Expenses | CA$35.98m |
Earnings | -CA$34.58m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.78 |
Gross Margin | 38.28% |
Net Profit Margin | -949.62% |
Debt/Equity Ratio | -98.2% |
How did CNVI perform over the long term?
See historical performance and comparison